These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30428665)

  • 21. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
    Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
    J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smart Drug Delivery Systems in Cancer Therapy.
    Unsoy G; Gunduz U
    Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvements in chemical carriers of proteins and peptides.
    Bolhassani A
    Cell Biol Int; 2019 Apr; 43(4):437-452. PubMed ID: 30672055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seek & Destroy, use of targeting peptides for cancer detection and drug delivery.
    Le Joncour V; Laakkonen P
    Bioorg Med Chem; 2018 Jun; 26(10):2797-2806. PubMed ID: 28893601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
    Moutinho CG; Matos CM; Teixeira JA; Balcão VM
    J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer.
    Kumar Giri T; Giri A; Kumar Barman T; Maity S
    Anticancer Agents Med Chem; 2016; 16(7):816-31. PubMed ID: 26567624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides.
    Batista P; Castro PM; Madureira AR; Sarmento B; Pintado M
    Peptides; 2018 Mar; 101():112-123. PubMed ID: 29329977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
    Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
    Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-targeted theranostic nanomedicines against cancer.
    Yao VJ; D'Angelo S; Butler KS; Theron C; Smith TL; Marchiò S; Gelovani JG; Sidman RL; Dobroff AS; Brinker CJ; Bradbury ARM; Arap W; Pasqualini R
    J Control Release; 2016 Oct; 240():267-286. PubMed ID: 26772878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
    Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
    Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral films as breakthrough tools for oral delivery of proteins/peptides.
    Castro PM; Fonte P; Sousa F; Madureira AR; Sarmento B; Pintado ME
    J Control Release; 2015 Aug; 211():63-73. PubMed ID: 25979328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nose-to-brain peptide delivery - The potential of nanotechnology.
    Samaridou E; Alonso MJ
    Bioorg Med Chem; 2018 Jun; 26(10):2888-2905. PubMed ID: 29170026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term delivery of protein and peptide therapeutics for cancer therapies.
    Sikder S; Gote V; Alshamrani M; Sicotte J; Pal D
    Expert Opin Drug Deliv; 2019 Oct; 16(10):1113-1131. PubMed ID: 31498012
    [No Abstract]   [Full Text] [Related]  

  • 36. Tailoring nanocarriers for intracellular protein delivery.
    Gu Z; Biswas A; Zhao M; Tang Y
    Chem Soc Rev; 2011 Jul; 40(7):3638-55. PubMed ID: 21566806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in Nanocarriers for Anticancer Drugs Delivery.
    Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
    Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.
    Abdelaziz HM; Gaber M; Abd-Elwakil MM; Mabrouk MT; Elgohary MM; Kamel NM; Kabary DM; Freag MS; Samaha MW; Mortada SM; Elkhodairy KA; Fang JY; Elzoghby AO
    J Control Release; 2018 Jan; 269():374-392. PubMed ID: 29180168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microfluidics: a focus on improved cancer targeted drug delivery systems.
    Khan IU; Serra CA; Anton N; Vandamme T
    J Control Release; 2013 Dec; 172(3):1065-74. PubMed ID: 23933524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.